Invention for Innovation

Vials and syringe

Invention for Innovation (i4i) is a translational funding scheme to advance healthcare technologies and interventions for increased patient benefit in areas of existing or emerging clinical need. Similarly, the Health Innovation Challenge Fund (HIC Fund), a partnership between the Department of Health and the Wellcome Trust, is also a translational funding scheme and complements the NIHR i4i Programme at a key translational gap.

i4i supports collaborative research and development projects that have demonstrated proof-of-principle and have a clear pathway towards adoption and commercialisation. The expected output is an advanced or clinically validated prototype medical device, technology or intervention. The aim is to de-risk projects and make them attractive to follow-on funders and investors.

There are two funding streams, Product Development awards and Challenge awards, which comprise early to late stage product development, including first-in-man and clinical feasibility studies and pivotal clinical studies to evaluate the safety and effectiveness for the intended use. The ultimate aim is to get products or services to a position where they can enter and be used within the NHS.

If you are unsure which i4i funding stream you should submit your application to, please email, providing a short summary of the proposed research.

The i4i programme has been independently evaluated by RAND Europe. An overview of the RAND report is provided in the attachment 'i4i programme RAND review' on this page  If you would like to request a copy of the full report please email




Apply/manage your award